Andrew Farquharson's most recent trade in Rani Therapeutics Holdings Inc - Ordinary Shares Class A was a trade of 50,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 28 May 2025 | 50,000 | 50,000 | - | - | Director Stock Option (Right to Buy) | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 16 Dec 2024 | 101,276 | 0 | - | - | Stock Option (Right to Buy) | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 16 Dec 2024 | 101,276 | 101,276 | - | - | Stock Option (Right to Buy) | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 29 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 16 Dec 2023 | 101,276 | 0 | - | - | Stock Option (Right to Buy) | ||
| Rani Therapeutics Holdings Inc | Farquharson Andrew | Director | 16 Dec 2023 | 101,276 | 101,276 | - | - | Stock Option (Right to Buy) | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 25 May 2023 | 101,276 | 101,276 | - | - | Stock Option (Right to Buy) | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 23 Aug 2022 | 7,694 | 72,818 | - | 0 | Class A Common Stock | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 23 Aug 2022 | 7,694 | 248,929 | - | 0 | Class B Common Stock | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 23 Aug 2022 | 7,694 | 248,929 | - | - | Class A Common LLC Units | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 25 May 2022 | 41,416 | 41,416 | - | - | Stock Option (Right to Buy) | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 07 Mar 2022 | 2,309,490 | 2,375,617 | - | 0 | Class A Common Stock | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 07 Mar 2022 | 2,309,490 | 256,623 | - | - | Class A Common LLC Units | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 07 Mar 2022 | 2,309,490 | 256,623 | - | 0 | Class B Common Stock | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 07 Mar 2022 | 2,229,238 | 146,379 | - | 0 | Class A Common Stock | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 03 Feb 2022 | 827,467 | 0 | - | 0 | Class A Common Stock | ||
| Rani Therapeutics Holdings Inc | Andrew Farquharson | Director | 03 Feb 2022 | 66,127 | 66,127 | - | 0 | Class A Common Stock |